

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.04577193 |
| 2 | protein maturation by protein folding (GO:0022417) | 5.02814072 |
| 3 | formation of translation preinitiation complex (GO:0001731) | 4.83708139 |
| 4 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.72754447 |
| 5 | COPI coating of Golgi vesicle (GO:0048205) | 4.69703183 |
| 6 | Golgi transport vesicle coating (GO:0048200) | 4.69703183 |
| 7 | folic acid metabolic process (GO:0046655) | 4.57406251 |
| 8 | nucleobase biosynthetic process (GO:0046112) | 4.52477321 |
| 9 | purine nucleobase biosynthetic process (GO:0009113) | 4.51693127 |
| 10 | ribosome assembly (GO:0042255) | 4.37278702 |
| 11 | ribosome biogenesis (GO:0042254) | 4.00791586 |
| 12 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.98919492 |
| 13 | mitotic nuclear envelope reassembly (GO:0007084) | 3.88748736 |
| 14 | nuclear envelope reassembly (GO:0031468) | 3.88748736 |
| 15 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.83006240 |
| 16 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.80856102 |
| 17 | pentose-phosphate shunt (GO:0006098) | 3.71592008 |
| 18 | GDP-mannose metabolic process (GO:0019673) | 3.68946680 |
| 19 | proline biosynthetic process (GO:0006561) | 3.68193143 |
| 20 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.66768372 |
| 21 | DNA replication checkpoint (GO:0000076) | 3.65958056 |
| 22 | mitotic metaphase plate congression (GO:0007080) | 3.62739511 |
| 23 | glycine metabolic process (GO:0006544) | 3.61514756 |
| 24 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.58630273 |
| 25 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.55547903 |
| 26 | establishment of integrated proviral latency (GO:0075713) | 3.52518673 |
| 27 | establishment of viral latency (GO:0019043) | 3.51624471 |
| 28 | maturation of SSU-rRNA (GO:0030490) | 3.50571887 |
| 29 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.50434861 |
| 30 | DNA replication initiation (GO:0006270) | 3.49891076 |
| 31 | regulation of translational termination (GO:0006449) | 3.49842606 |
| 32 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.47587977 |
| 33 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.46596801 |
| 34 | DNA strand elongation (GO:0022616) | 3.45730852 |
| 35 | protein retention in ER lumen (GO:0006621) | 3.42819848 |
| 36 | protein localization to kinetochore (GO:0034501) | 3.40356042 |
| 37 | mitotic nuclear envelope disassembly (GO:0007077) | 3.40015249 |
| 38 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.39824825 |
| 39 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.38282472 |
| 40 | NADPH regeneration (GO:0006740) | 3.37896549 |
| 41 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.33001907 |
| 42 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.31958823 |
| 43 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.26126614 |
| 44 | negative regulation of ligase activity (GO:0051352) | 3.26126614 |
| 45 | glucose catabolic process (GO:0006007) | 3.22626493 |
| 46 | IMP biosynthetic process (GO:0006188) | 3.22138416 |
| 47 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.19230817 |
| 48 | rRNA modification (GO:0000154) | 3.18520521 |
| 49 | L-methionine salvage (GO:0071267) | 3.18300045 |
| 50 | L-methionine biosynthetic process (GO:0071265) | 3.18300045 |
| 51 | amino acid salvage (GO:0043102) | 3.18300045 |
| 52 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.17583762 |
| 53 | folic acid transport (GO:0015884) | 3.15565990 |
| 54 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.14782515 |
| 55 | membrane disassembly (GO:0030397) | 3.12769127 |
| 56 | nuclear envelope disassembly (GO:0051081) | 3.12769127 |
| 57 | spliceosomal snRNP assembly (GO:0000387) | 3.10275584 |
| 58 | ribosomal large subunit biogenesis (GO:0042273) | 3.07788801 |
| 59 | mitotic chromosome condensation (GO:0007076) | 3.07271287 |
| 60 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.07149165 |
| 61 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.06890553 |
| 62 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.06890553 |
| 63 | ribosomal small subunit biogenesis (GO:0042274) | 3.05726463 |
| 64 | pentose metabolic process (GO:0019321) | 3.05378895 |
| 65 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.05295253 |
| 66 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.05295253 |
| 67 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.05295253 |
| 68 | DNA unwinding involved in DNA replication (GO:0006268) | 3.05230177 |
| 69 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.05091372 |
| 70 | rRNA processing (GO:0006364) | 3.04053321 |
| 71 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.03782668 |
| 72 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.02670853 |
| 73 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.02670853 |
| 74 | pyrimidine-containing compound salvage (GO:0008655) | 3.01850714 |
| 75 | pyrimidine nucleoside salvage (GO:0043097) | 3.01850714 |
| 76 | histone arginine methylation (GO:0034969) | 3.01752557 |
| 77 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.01391191 |
| 78 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.00967031 |
| 79 | positive regulation of ligase activity (GO:0051351) | 3.00864282 |
| 80 | pseudouridine synthesis (GO:0001522) | 3.00024153 |
| 81 | regulation of mitochondrial translation (GO:0070129) | 2.99818299 |
| 82 | methionine biosynthetic process (GO:0009086) | 2.98303498 |
| 83 | maturation of 5.8S rRNA (GO:0000460) | 2.93348733 |
| 84 | rRNA metabolic process (GO:0016072) | 2.92956121 |
| 85 | protein localization to chromosome, centromeric region (GO:0071459) | 2.92268419 |
| 86 | pinocytosis (GO:0006907) | 2.92035090 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 2.91594256 |
| 88 | * proteasome assembly (GO:0043248) | 2.90484688 |
| 89 | translational initiation (GO:0006413) | 2.89201709 |
| 90 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.88852702 |
| 91 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.88852702 |
| 92 | NADH metabolic process (GO:0006734) | 2.88541676 |
| 93 | L-serine metabolic process (GO:0006563) | 2.88367083 |
| 94 | regulation of spindle organization (GO:0090224) | 2.88312163 |
| 95 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.88149710 |
| 96 | sulfur amino acid biosynthetic process (GO:0000097) | 2.88146577 |
| 97 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.86664077 |
| 98 | termination of RNA polymerase III transcription (GO:0006386) | 2.86664077 |
| 99 | folic acid-containing compound metabolic process (GO:0006760) | 2.86651991 |
| 100 | regulation of translation in response to stress (GO:0043555) | 2.85362322 |
| 101 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.85272384 |
| 102 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.84049495 |
| 103 | protein complex localization (GO:0031503) | 2.83938185 |
| 104 | nucleoside salvage (GO:0043174) | 2.81803014 |
| 105 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.81664402 |
| 106 | cell cycle G1/S phase transition (GO:0044843) | 2.81664402 |
| 107 | metaphase plate congression (GO:0051310) | 2.78193764 |
| 108 | methionine metabolic process (GO:0006555) | 2.77883356 |
| 109 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.76391766 |
| 110 | negative regulation of translational initiation (GO:0045947) | 2.75825267 |
| 111 | telomere maintenance via recombination (GO:0000722) | 2.74532231 |
| 112 | nucleotide salvage (GO:0043173) | 2.73787972 |
| 113 | regulation of translational fidelity (GO:0006450) | 2.73353272 |
| 114 | IMP metabolic process (GO:0046040) | 2.73265392 |
| 115 | negative regulation of cell size (GO:0045792) | 2.72341198 |
| 116 | mitochondrial fusion (GO:0008053) | 2.71294857 |
| 117 | regulation of ligase activity (GO:0051340) | 2.70114764 |
| 118 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.70031415 |
| 119 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.69202670 |
| 120 | barbed-end actin filament capping (GO:0051016) | 2.68891593 |
| 121 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.68769120 |
| 122 | positive regulation of cell cycle arrest (GO:0071158) | 2.68562582 |
| 123 | telomere maintenance via telomere lengthening (GO:0010833) | 2.65368982 |
| 124 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.64485169 |
| 125 | positive regulation of chromosome segregation (GO:0051984) | 2.64032424 |
| 126 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.63739487 |
| 127 | serine family amino acid metabolic process (GO:0009069) | 2.63687495 |
| 128 | protein localization to endosome (GO:0036010) | 2.63364330 |
| 129 | peptidyl-arginine methylation (GO:0018216) | 2.63261889 |
| 130 | peptidyl-arginine N-methylation (GO:0035246) | 2.63261889 |
| 131 | nuclear envelope organization (GO:0006998) | 2.62109439 |
| 132 | tRNA methylation (GO:0030488) | 2.60799422 |
| 133 | tetrahydrofolate metabolic process (GO:0046653) | 2.60070532 |
| 134 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.59542957 |
| 135 | ribosomal small subunit assembly (GO:0000028) | 2.59145544 |
| 136 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.59054491 |
| 137 | regulation of gene silencing by miRNA (GO:0060964) | 2.59054491 |
| 138 | regulation of gene silencing by RNA (GO:0060966) | 2.59054491 |
| 139 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.58245998 |
| 140 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.58220391 |
| 141 | mitotic sister chromatid segregation (GO:0000070) | 2.57091378 |
| 142 | NIK/NF-kappaB signaling (GO:0038061) | 2.56628481 |
| 143 | monosaccharide biosynthetic process (GO:0046364) | 2.56604469 |
| 144 | cellular protein complex localization (GO:0034629) | 2.56195784 |
| 145 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.56168341 |
| 146 | cullin deneddylation (GO:0010388) | 2.54598778 |
| 147 | protein deneddylation (GO:0000338) | 2.54486266 |
| 148 | negative regulation of chromosome segregation (GO:0051985) | 2.53631763 |
| 149 | rRNA transcription (GO:0009303) | 2.52767030 |
| 150 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.52657360 |
| 151 | protein targeting to mitochondrion (GO:0006626) | 2.52032508 |
| 152 | transcription from mitochondrial promoter (GO:0006390) | 2.51921030 |
| 153 | pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209) | 2.50554987 |
| 154 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.49371294 |
| 155 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.48171838 |
| 156 | regulation of cellular amine metabolic process (GO:0033238) | 2.47742019 |
| 157 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.45567042 |
| 158 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.45567042 |
| 159 | heterochromatin organization (GO:0070828) | 2.45491949 |
| 160 | de novo protein folding (GO:0006458) | 2.42735012 |
| 161 | gluconeogenesis (GO:0006094) | 2.42141321 |
| 162 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.41930116 |
| 163 | apoptotic process involved in morphogenesis (GO:0060561) | 2.41889100 |
| 164 | de novo posttranslational protein folding (GO:0051084) | 2.41614317 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.04379676 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.82177672 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.68336719 |
| 4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.82113104 |
| 5 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.78814927 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.72120899 |
| 7 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.66646210 |
| 8 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.64382798 |
| 9 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.49299593 |
| 10 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.46093669 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.45811341 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.42899998 |
| 13 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.40979017 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.34124553 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.27497073 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.13984498 |
| 17 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.11919184 |
| 18 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.06316389 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.93763606 |
| 20 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.89204748 |
| 21 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.88269654 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.85475520 |
| 23 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.84660387 |
| 24 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.84042914 |
| 25 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.83942588 |
| 26 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.83444686 |
| 27 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.81363609 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.79363202 |
| 29 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.77972105 |
| 30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.71988870 |
| 31 | MYC_22102868_ChIP-Seq_BL_Human | 1.70115600 |
| 32 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.68476683 |
| 33 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.67188640 |
| 34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.67138289 |
| 35 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.66361556 |
| 36 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.65966388 |
| 37 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.64781919 |
| 38 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.63316123 |
| 39 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.62518683 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.60962166 |
| 41 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.60756973 |
| 42 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.55871094 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51977207 |
| 44 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.47994616 |
| 45 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.47988728 |
| 46 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.47981921 |
| 47 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.47948263 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.46259320 |
| 49 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.45931053 |
| 50 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.44823289 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42472039 |
| 52 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41651150 |
| 53 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.40538980 |
| 54 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.40371156 |
| 55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39761336 |
| 56 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.39018940 |
| 57 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.38559684 |
| 58 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.37785966 |
| 59 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36670511 |
| 60 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.34729043 |
| 61 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31844477 |
| 62 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.31463476 |
| 63 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.31291775 |
| 64 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.30304755 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.25367963 |
| 66 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.24173567 |
| 67 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.23983190 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23958943 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23759125 |
| 70 | P68_20966046_ChIP-Seq_HELA_Human | 1.23168161 |
| 71 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.22987356 |
| 72 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.22794439 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.22401122 |
| 74 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.21510081 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.21230532 |
| 76 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17287133 |
| 77 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.14405264 |
| 78 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.11558310 |
| 79 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.10388288 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09815368 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09544746 |
| 82 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.09079297 |
| 83 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09076731 |
| 84 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08887397 |
| 85 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.08153851 |
| 86 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07653850 |
| 87 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.06789157 |
| 88 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06610860 |
| 89 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.06403763 |
| 90 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.06198922 |
| 91 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05370716 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04147515 |
| 93 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.03861774 |
| 94 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03685598 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03560693 |
| 96 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.02906730 |
| 97 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.02568810 |
| 98 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.02180480 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.01896911 |
| 100 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.00759348 |
| 101 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.00280418 |
| 102 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.99978728 |
| 103 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.99793532 |
| 104 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.99651505 |
| 105 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99133716 |
| 106 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.98623325 |
| 107 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.97959963 |
| 108 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.97405259 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97018155 |
| 110 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.96991070 |
| 111 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.96893894 |
| 112 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96797032 |
| 113 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96447241 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.96434529 |
| 115 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96119368 |
| 116 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95979216 |
| 117 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95672557 |
| 118 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94890790 |
| 119 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94329078 |
| 120 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.92014205 |
| 121 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.91862716 |
| 122 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.91085112 |
| 123 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.90787917 |
| 124 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.90787917 |
| 125 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.90787917 |
| 126 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90335539 |
| 127 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.89509020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.88132249 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.86302327 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.77153475 |
| 4 | MP0002877_abnormal_melanocyte_morpholog | 3.32335970 |
| 5 | MP0009840_abnormal_foam_cell | 3.18504243 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.11067947 |
| 7 | MP0003077_abnormal_cell_cycle | 3.09215048 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.96805007 |
| 9 | MP0001730_embryonic_growth_arrest | 2.32552622 |
| 10 | MP0010352_gastrointestinal_tract_polyps | 2.31936947 |
| 11 | MP0004233_abnormal_muscle_weight | 2.21948216 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.13616958 |
| 13 | MP0008058_abnormal_DNA_repair | 2.10377674 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.09626109 |
| 15 | MP0008007_abnormal_cellular_replicative | 2.02748362 |
| 16 | MP0003718_maternal_effect | 1.99885282 |
| 17 | MP0002796_impaired_skin_barrier | 1.99603285 |
| 18 | MP0008057_abnormal_DNA_replication | 1.92922013 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 1.90177832 |
| 20 | MP0010234_abnormal_vibrissa_follicle | 1.83803613 |
| 21 | MP0004185_abnormal_adipocyte_glucose | 1.83446999 |
| 22 | MP0003453_abnormal_keratinocyte_physiol | 1.83288173 |
| 23 | MP0000350_abnormal_cell_proliferation | 1.80627373 |
| 24 | MP0003786_premature_aging | 1.73776758 |
| 25 | MP0003186_abnormal_redox_activity | 1.63572035 |
| 26 | MP0001672_abnormal_embryogenesis/_devel | 1.62273075 |
| 27 | MP0005380_embryogenesis_phenotype | 1.62273075 |
| 28 | MP0001697_abnormal_embryo_size | 1.55437000 |
| 29 | MP0004858_abnormal_nervous_system | 1.54856174 |
| 30 | MP0002080_prenatal_lethality | 1.53314315 |
| 31 | MP0005360_urolithiasis | 1.52802322 |
| 32 | MP0010307_abnormal_tumor_latency | 1.51922588 |
| 33 | MP0003984_embryonic_growth_retardation | 1.49166584 |
| 34 | MP0002088_abnormal_embryonic_growth/wei | 1.47373989 |
| 35 | MP0003123_paternal_imprinting | 1.47007392 |
| 36 | MP0000678_abnormal_parathyroid_gland | 1.45360807 |
| 37 | MP0009333_abnormal_splenocyte_physiolog | 1.43320219 |
| 38 | MP0005257_abnormal_intraocular_pressure | 1.41709942 |
| 39 | MP0005365_abnormal_bile_salt | 1.38980209 |
| 40 | MP0005397_hematopoietic_system_phenotyp | 1.37607709 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.37607709 |
| 42 | MP0008438_abnormal_cutaneous_collagen | 1.33252308 |
| 43 | MP0005085_abnormal_gallbladder_physiolo | 1.32825313 |
| 44 | MP0002060_abnormal_skin_morphology | 1.32626675 |
| 45 | MP0002396_abnormal_hematopoietic_system | 1.32384209 |
| 46 | MP0000750_abnormal_muscle_regeneration | 1.31909643 |
| 47 | MP0000751_myopathy | 1.31802116 |
| 48 | MP0010030_abnormal_orbit_morphology | 1.30560832 |
| 49 | MP0002086_abnormal_extraembryonic_tissu | 1.29929150 |
| 50 | MP0002653_abnormal_ependyma_morphology | 1.28918738 |
| 51 | MP0000747_muscle_weakness | 1.28753542 |
| 52 | MP0000490_abnormal_crypts_of | 1.28651297 |
| 53 | MP0005670_abnormal_white_adipose | 1.27220556 |
| 54 | MP0000343_altered_response_to | 1.26941040 |
| 55 | MP0000358_abnormal_cell_content/ | 1.26148336 |
| 56 | MP0002085_abnormal_embryonic_tissue | 1.23739015 |
| 57 | MP0000313_abnormal_cell_death | 1.22557757 |
| 58 | MP0002019_abnormal_tumor_incidence | 1.21635050 |
| 59 | MP0000537_abnormal_urethra_morphology | 1.20898716 |
| 60 | MP0004197_abnormal_fetal_growth/weight/ | 1.19637039 |
| 61 | MP0000749_muscle_degeneration | 1.19594355 |
| 62 | MP0002269_muscular_atrophy | 1.19115843 |
| 63 | MP0001216_abnormal_epidermal_layer | 1.16235233 |
| 64 | MP0004510_myositis | 1.15951857 |
| 65 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15430093 |
| 66 | MP0002084_abnormal_developmental_patter | 1.15311815 |
| 67 | MP0005332_abnormal_amino_acid | 1.13392774 |
| 68 | MP0006036_abnormal_mitochondrial_physio | 1.13371198 |
| 69 | MP0005023_abnormal_wound_healing | 1.11674448 |
| 70 | MP0005451_abnormal_body_composition | 1.11440826 |
| 71 | MP0003191_abnormal_cellular_cholesterol | 1.11264964 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.11124930 |
| 73 | MP0003566_abnormal_cell_adhesion | 1.07504211 |
| 74 | MP0005319_abnormal_enzyme/_coenzyme | 1.07421850 |
| 75 | MP0004272_abnormal_basement_membrane | 1.05925651 |
| 76 | MP0009053_abnormal_anal_canal | 1.05002527 |
| 77 | MP0003172_abnormal_lysosome_physiology | 1.04814521 |
| 78 | MP0003119_abnormal_digestive_system | 1.03628018 |
| 79 | MP0000609_abnormal_liver_physiology | 1.03142261 |
| 80 | MP0003646_muscle_fatigue | 1.03016011 |
| 81 | MP0003436_decreased_susceptibility_to | 1.02977760 |
| 82 | MP0003567_abnormal_fetal_cardiomyocyte | 1.02139014 |
| 83 | MP0000003_abnormal_adipose_tissue | 1.01597045 |
| 84 | MP0000598_abnormal_liver_morphology | 1.01411567 |
| 85 | MP0008260_abnormal_autophagy | 1.01389083 |
| 86 | MP0009278_abnormal_bone_marrow | 1.00656217 |
| 87 | MP0000733_abnormal_muscle_development | 1.00513348 |
| 88 | MP0006035_abnormal_mitochondrial_morpho | 1.00355493 |
| 89 | MP0005623_abnormal_meninges_morphology | 0.99810792 |
| 90 | MP0004019_abnormal_vitamin_homeostasis | 0.99418978 |
| 91 | MP0000759_abnormal_skeletal_muscle | 0.98930814 |
| 92 | MP0003315_abnormal_perineum_morphology | 0.98663535 |
| 93 | MP0005165_increased_susceptibility_to | 0.97911580 |
| 94 | MP0000858_altered_metastatic_potential | 0.96056791 |
| 95 | MP0003075_altered_response_to | 0.94346861 |
| 96 | MP0001243_abnormal_dermal_layer | 0.93927599 |
| 97 | MP0004947_skin_inflammation | 0.93718234 |
| 98 | MP0001849_ear_inflammation | 0.93207381 |
| 99 | MP0005666_abnormal_adipose_tissue | 0.92766696 |
| 100 | MP0002132_abnormal_respiratory_system | 0.92274480 |
| 101 | MP0001881_abnormal_mammary_gland | 0.90029876 |
| 102 | MP0005083_abnormal_biliary_tract | 0.88915723 |
| 103 | MP0000467_abnormal_esophagus_morphology | 0.88606714 |
| 104 | MP0005375_adipose_tissue_phenotype | 0.86944902 |
| 105 | MP0005395_other_phenotype | 0.86470321 |
| 106 | MP0005076_abnormal_cell_differentiation | 0.85260094 |
| 107 | MP0003941_abnormal_skin_development | 0.84335875 |
| 108 | MP0002148_abnormal_hypersensitivity_rea | 0.83913746 |
| 109 | MP0002254_reproductive_system_inflammat | 0.83305733 |
| 110 | MP0005058_abnormal_lysosome_morphology | 0.82782861 |
| 111 | MP0009931_abnormal_skin_appearance | 0.81834963 |
| 112 | MP0005377_hearing/vestibular/ear_phenot | 0.81553368 |
| 113 | MP0003878_abnormal_ear_physiology | 0.81553368 |
| 114 | MP0009643_abnormal_urine_homeostasis | 0.81375506 |
| 115 | MP0010329_abnormal_lipoprotein_level | 0.81115295 |
| 116 | MP0003448_altered_tumor_morphology | 0.80425356 |
| 117 | MP0001764_abnormal_homeostasis | 0.80341413 |
| 118 | MP0002089_abnormal_postnatal_growth/wei | 0.79193720 |
| 119 | MP0005464_abnormal_platelet_physiology | 0.78296174 |
| 120 | MP0010771_integument_phenotype | 0.77322914 |
| 121 | MP0001727_abnormal_embryo_implantation | 0.75441991 |
| 122 | MP0001756_abnormal_urination | 0.75396860 |
| 123 | MP0005384_cellular_phenotype | 0.75236567 |
| 124 | MP0008877_abnormal_DNA_methylation | 0.75208772 |
| 125 | * MP0002722_abnormal_immune_system | 0.75047480 |
| 126 | MP0000689_abnormal_spleen_morphology | 0.74910844 |
| 127 | MP0004087_abnormal_muscle_fiber | 0.74833418 |
| 128 | MP0005330_cardiomyopathy | 0.74712298 |
| 129 | MP0003303_peritoneal_inflammation | 0.74322708 |
| 130 | MP0005621_abnormal_cell_physiology | 0.74054497 |
| 131 | MP0002332_abnormal_exercise_endurance | 0.72567890 |
| 132 | MP0005266_abnormal_metabolism | 0.72553644 |
| 133 | MP0002210_abnormal_sex_determination | 0.71389624 |
| 134 | MP0005501_abnormal_skin_physiology | 0.70428672 |
| 135 | MP0001853_heart_inflammation | 0.69543469 |
| 136 | MP0004084_abnormal_cardiac_muscle | 0.69509597 |
| 137 | * MP0001145_abnormal_male_reproductive | 0.69372920 |
| 138 | MP0002111_abnormal_tail_morphology | 0.69071992 |
| 139 | MP0003763_abnormal_thymus_physiology | 0.67653376 |
| 140 | * MP0009672_abnormal_birth_weight | 0.66630679 |
| 141 | MP0000477_abnormal_intestine_morphology | 0.63868410 |
| 142 | MP0001661_extended_life_span | 0.62819747 |
| 143 | MP0004808_abnormal_hematopoietic_stem | 0.61292227 |
| 144 | MP0001915_intracranial_hemorrhage | 0.60978301 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Breast hypoplasia (HP:0003187) | 4.46180730 |
| 2 | Multiple enchondromatosis (HP:0005701) | 4.17277987 |
| 3 | Birth length less than 3rd percentile (HP:0003561) | 4.00847649 |
| 4 | Carpal bone hypoplasia (HP:0001498) | 3.58341824 |
| 5 | Cerebral hypomyelination (HP:0006808) | 3.47740667 |
| 6 | Degeneration of anterior horn cells (HP:0002398) | 3.47244372 |
| 7 | Abnormality of the anterior horn cell (HP:0006802) | 3.47244372 |
| 8 | Vertebral compression fractures (HP:0002953) | 3.39419124 |
| 9 | Distal lower limb muscle weakness (HP:0009053) | 3.39125837 |
| 10 | Achilles tendon contracture (HP:0001771) | 3.35605880 |
| 11 | Ragged-red muscle fibers (HP:0003200) | 3.33639430 |
| 12 | Oral leukoplakia (HP:0002745) | 3.30073898 |
| 13 | Rough bone trabeculation (HP:0100670) | 3.26642106 |
| 14 | Distal lower limb amyotrophy (HP:0008944) | 3.24390431 |
| 15 | Cholecystitis (HP:0001082) | 3.24201366 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 3.24201366 |
| 17 | Hyperglycinemia (HP:0002154) | 3.23673372 |
| 18 | Trismus (HP:0000211) | 3.21282088 |
| 19 | Hyperglycinuria (HP:0003108) | 3.17595323 |
| 20 | Premature ovarian failure (HP:0008209) | 3.11268052 |
| 21 | Abnormality of the Achilles tendon (HP:0005109) | 3.00059848 |
| 22 | Abnormality of glycolipid metabolism (HP:0010969) | 2.92066600 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.92066600 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.92066600 |
| 25 | Patellar aplasia (HP:0006443) | 2.91820159 |
| 26 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.87790203 |
| 27 | Progressive muscle weakness (HP:0003323) | 2.80845014 |
| 28 | Premature rupture of membranes (HP:0001788) | 2.77633274 |
| 29 | Selective tooth agenesis (HP:0001592) | 2.75948445 |
| 30 | Secondary amenorrhea (HP:0000869) | 2.71718145 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.70456156 |
| 32 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67469301 |
| 33 | Distal upper limb amyotrophy (HP:0007149) | 2.63055465 |
| 34 | Upper limb amyotrophy (HP:0009129) | 2.63055465 |
| 35 | Nausea (HP:0002018) | 2.62056723 |
| 36 | Increased connective tissue (HP:0009025) | 2.61431804 |
| 37 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.60841883 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 2.60841883 |
| 39 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.59079239 |
| 40 | Hypokinesia (HP:0002375) | 2.56211628 |
| 41 | Hyperacusis (HP:0010780) | 2.54184988 |
| 42 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.51242657 |
| 43 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.50857440 |
| 44 | Microretrognathia (HP:0000308) | 2.49068194 |
| 45 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.48410795 |
| 46 | Microvesicular hepatic steatosis (HP:0001414) | 2.47876846 |
| 47 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.46719728 |
| 48 | Abnormal cartilage morphology (HP:0002763) | 2.44710859 |
| 49 | Impulsivity (HP:0100710) | 2.42911345 |
| 50 | Megaloblastic anemia (HP:0001889) | 2.40468548 |
| 51 | Axonal loss (HP:0003447) | 2.40003511 |
| 52 | Abnormal number of erythroid precursors (HP:0012131) | 2.39575996 |
| 53 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.38050350 |
| 54 | Personality changes (HP:0000751) | 2.37664324 |
| 55 | Hypobetalipoproteinemia (HP:0003563) | 2.37650450 |
| 56 | Short nail (HP:0001799) | 2.36578218 |
| 57 | Generalized amyotrophy (HP:0003700) | 2.35315534 |
| 58 | Abnormality of glycolysis (HP:0004366) | 2.35264594 |
| 59 | Gout (HP:0001997) | 2.34951609 |
| 60 | Myopathic facies (HP:0002058) | 2.34463629 |
| 61 | Abnormality of serum amino acid levels (HP:0003112) | 2.32776218 |
| 62 | Abnormal trabecular bone morphology (HP:0100671) | 2.30252771 |
| 63 | Ependymoma (HP:0002888) | 2.27714754 |
| 64 | Difficulty climbing stairs (HP:0003551) | 2.26957299 |
| 65 | Hyperammonemia (HP:0001987) | 2.21086522 |
| 66 | Abnormal neuron morphology (HP:0012757) | 2.19454297 |
| 67 | Abnormality of the motor neurons (HP:0002450) | 2.19454297 |
| 68 | Rhabdomyolysis (HP:0003201) | 2.14895795 |
| 69 | Fasciculations (HP:0002380) | 2.14485242 |
| 70 | Abnormality of the umbilical cord (HP:0010881) | 2.12873249 |
| 71 | Broad distal phalanx of finger (HP:0009836) | 2.12098141 |
| 72 | Absent thumb (HP:0009777) | 2.10266663 |
| 73 | Lower limb amyotrophy (HP:0007210) | 2.10168711 |
| 74 | Reticulocytopenia (HP:0001896) | 2.10096386 |
| 75 | Neoplasm of the pancreas (HP:0002894) | 2.09138211 |
| 76 | Prolonged neonatal jaundice (HP:0006579) | 2.07087591 |
| 77 | Ureteral duplication (HP:0000073) | 2.06964000 |
| 78 | Macrocytic anemia (HP:0001972) | 2.05962559 |
| 79 | Death in infancy (HP:0001522) | 2.05657235 |
| 80 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.02082514 |
| 81 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.02082514 |
| 82 | Absent radius (HP:0003974) | 2.01967299 |
| 83 | Hypertensive crisis (HP:0100735) | 2.01836174 |
| 84 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.01739251 |
| 85 | Pustule (HP:0200039) | 2.01565043 |
| 86 | Ulnar bowing (HP:0003031) | 2.01545295 |
| 87 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.99956255 |
| 88 | Stridor (HP:0010307) | 1.99595542 |
| 89 | Increased cerebral lipofuscin (HP:0011813) | 1.99594072 |
| 90 | Breech presentation (HP:0001623) | 1.98143707 |
| 91 | Abnormality of reticulocytes (HP:0004312) | 1.97158769 |
| 92 | Muscle fibrillation (HP:0010546) | 1.96327663 |
| 93 | Nuclear cataract (HP:0100018) | 1.95965367 |
| 94 | Elbow flexion contracture (HP:0002987) | 1.95610465 |
| 95 | Hepatosplenomegaly (HP:0001433) | 1.95204713 |
| 96 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.93781785 |
| 97 | Sparse eyelashes (HP:0000653) | 1.93659197 |
| 98 | Increased intramyocellular lipid droplets (HP:0012240) | 1.92611774 |
| 99 | Increased serum pyruvate (HP:0003542) | 1.92464224 |
| 100 | Spinal muscular atrophy (HP:0007269) | 1.90968775 |
| 101 | Reticulocytosis (HP:0001923) | 1.89881360 |
| 102 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.89583153 |
| 103 | Dicarboxylic aciduria (HP:0003215) | 1.89583153 |
| 104 | Type I transferrin isoform profile (HP:0003642) | 1.88931219 |
| 105 | Increased muscle lipid content (HP:0009058) | 1.88674783 |
| 106 | Tongue fasciculations (HP:0001308) | 1.87773421 |
| 107 | Long palpebral fissure (HP:0000637) | 1.87640732 |
| 108 | Hand muscle atrophy (HP:0009130) | 1.87088043 |
| 109 | Xanthomatosis (HP:0000991) | 1.85236243 |
| 110 | Poor head control (HP:0002421) | 1.84384814 |
| 111 | J-shaped sella turcica (HP:0002680) | 1.84208322 |
| 112 | CNS demyelination (HP:0007305) | 1.83799999 |
| 113 | Areflexia of lower limbs (HP:0002522) | 1.83729130 |
| 114 | Upper limb muscle weakness (HP:0003484) | 1.83667155 |
| 115 | Aplasia involving forearm bones (HP:0009822) | 1.83652136 |
| 116 | Absent forearm bone (HP:0003953) | 1.83652136 |
| 117 | Diaphragmatic weakness (HP:0009113) | 1.83152521 |
| 118 | Bulbar palsy (HP:0001283) | 1.83078859 |
| 119 | Spinal rigidity (HP:0003306) | 1.81566029 |
| 120 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81472120 |
| 121 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.81136291 |
| 122 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.81024953 |
| 123 | Single umbilical artery (HP:0001195) | 1.81024953 |
| 124 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.81024953 |
| 125 | Polycythemia (HP:0001901) | 1.80692236 |
| 126 | Entropion (HP:0000621) | 1.79789079 |
| 127 | Vacuolated lymphocytes (HP:0001922) | 1.79730891 |
| 128 | Back pain (HP:0003418) | 1.79606906 |
| 129 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79181220 |
| 130 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.78502614 |
| 131 | Progressive neurologic deterioration (HP:0002344) | 1.77822270 |
| 132 | CNS hypomyelination (HP:0003429) | 1.77015295 |
| 133 | Cholelithiasis (HP:0001081) | 1.76783323 |
| 134 | Premature graying of hair (HP:0002216) | 1.75699057 |
| 135 | Micronodular cirrhosis (HP:0001413) | 1.75164391 |
| 136 | Lethargy (HP:0001254) | 1.75015419 |
| 137 | Reduced antithrombin III activity (HP:0001976) | 1.74952555 |
| 138 | Petechiae (HP:0000967) | 1.74895442 |
| 139 | Dysostosis multiplex (HP:0000943) | 1.74864635 |
| 140 | Spastic diplegia (HP:0001264) | 1.74307427 |
| 141 | Loss of speech (HP:0002371) | 1.74298386 |
| 142 | Upper motor neuron abnormality (HP:0002127) | 1.74138092 |
| 143 | Cellular immunodeficiency (HP:0005374) | 1.73681034 |
| 144 | Testicular atrophy (HP:0000029) | 1.73246869 |
| 145 | Deviation of the thumb (HP:0009603) | 1.72795874 |
| 146 | Spastic paraparesis (HP:0002313) | 1.72185547 |
| 147 | Osteolytic defects of the hand bones (HP:0009699) | 1.71815756 |
| 148 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.71815756 |
| 149 | Increased serum ferritin (HP:0003281) | 1.71248910 |
| 150 | Abnormality of nucleobase metabolism (HP:0010932) | 1.71189918 |
| 151 | Proximal placement of thumb (HP:0009623) | 1.69718768 |
| 152 | Limb-girdle muscle atrophy (HP:0003797) | 1.69238271 |
| 153 | Abnormality of the tricuspid valve (HP:0001702) | 1.69157292 |
| 154 | Adenoma sebaceum (HP:0009720) | 1.68523935 |
| 155 | Angiofibromas (HP:0010615) | 1.68523935 |
| 156 | Hypolipoproteinemia (HP:0010981) | 1.68226806 |
| 157 | Squamous cell carcinoma (HP:0002860) | 1.66459098 |
| 158 | Nonimmune hydrops fetalis (HP:0001790) | 1.66390379 |
| 159 | Colon cancer (HP:0003003) | 1.65704608 |
| 160 | Broad face (HP:0000283) | 1.65247870 |
| 161 | Exercise intolerance (HP:0003546) | 1.65239061 |
| 162 | Insomnia (HP:0100785) | 1.64813337 |
| 163 | Slender long bone (HP:0003100) | 1.64245656 |
| 164 | Progressive external ophthalmoplegia (HP:0000590) | 1.63845860 |
| 165 | Myocardial infarction (HP:0001658) | 1.63016345 |
| 166 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.62295029 |
| 167 | Pelvic girdle muscle weakness (HP:0003749) | 1.62096363 |
| 168 | Opisthotonus (HP:0002179) | 1.61893383 |
| 169 | Horseshoe kidney (HP:0000085) | 1.61631128 |
| 170 | Muscle fiber splitting (HP:0003555) | 1.59526569 |
| 171 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.58569205 |
| 172 | Posterior subcapsular cataract (HP:0007787) | 1.58169972 |
| 173 | Increased serum lactate (HP:0002151) | 1.57578460 |
| 174 | Rhabdomyosarcoma (HP:0002859) | 1.57484116 |
| 175 | Metaphyseal cupping (HP:0003021) | 1.57237252 |
| 176 | Abnormality of the lower motor neuron (HP:0002366) | 1.56531261 |
| 177 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.56459960 |
| 178 | Abnormality of the calcaneus (HP:0008364) | 1.56069058 |
| 179 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.56046623 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.34881855 |
| 2 | WEE1 | 3.43779746 |
| 3 | SMG1 | 3.06547583 |
| 4 | EPHA2 | 3.02205981 |
| 5 | EIF2AK1 | 2.99893336 |
| 6 | VRK2 | 2.80779726 |
| 7 | TESK2 | 2.59219458 |
| 8 | NEK2 | 2.49386620 |
| 9 | NEK1 | 2.36523207 |
| 10 | NME2 | 2.20703866 |
| 11 | TSSK6 | 2.19467365 |
| 12 | BCKDK | 2.13704910 |
| 13 | TTK | 2.08814261 |
| 14 | MAP3K11 | 1.97476877 |
| 15 | TRIB3 | 1.93717501 |
| 16 | PLK4 | 1.92565452 |
| 17 | CDC7 | 1.84923918 |
| 18 | SIK1 | 1.78162438 |
| 19 | ERN1 | 1.73272740 |
| 20 | STK16 | 1.65400378 |
| 21 | PBK | 1.64540453 |
| 22 | MST1R | 1.63754557 |
| 23 | KDR | 1.61172470 |
| 24 | PLK1 | 1.60554913 |
| 25 | DYRK3 | 1.51730711 |
| 26 | RPS6KA4 | 1.51052189 |
| 27 | ACVR1B | 1.49872773 |
| 28 | PIM2 | 1.49665196 |
| 29 | MAP3K10 | 1.46009609 |
| 30 | MAP3K8 | 1.43909570 |
| 31 | TESK1 | 1.41967637 |
| 32 | CDK7 | 1.40844057 |
| 33 | PRPF4B | 1.40547209 |
| 34 | SRPK1 | 1.38517036 |
| 35 | PAK4 | 1.33680198 |
| 36 | BRSK2 | 1.32464973 |
| 37 | CDK4 | 1.26520630 |
| 38 | RPS6KB2 | 1.25623539 |
| 39 | PKN2 | 1.23809456 |
| 40 | AURKA | 1.21935022 |
| 41 | AURKB | 1.21415862 |
| 42 | LATS2 | 1.20698983 |
| 43 | CDK12 | 1.20653108 |
| 44 | EIF2AK3 | 1.19904114 |
| 45 | STK10 | 1.15493990 |
| 46 | SCYL2 | 1.15303009 |
| 47 | BRSK1 | 1.07718477 |
| 48 | MAP4K1 | 1.07292756 |
| 49 | STK38L | 1.04567257 |
| 50 | LMTK2 | 1.04094872 |
| 51 | MAP2K3 | 1.03505821 |
| 52 | TAOK1 | 1.02047519 |
| 53 | DAPK1 | 1.01319249 |
| 54 | TAOK2 | 0.99304950 |
| 55 | CHEK2 | 0.98835123 |
| 56 | ATR | 0.98712083 |
| 57 | MAP3K3 | 0.94676389 |
| 58 | MAPKAPK3 | 0.93909972 |
| 59 | BRAF | 0.92055713 |
| 60 | EEF2K | 0.90925150 |
| 61 | PAK1 | 0.90579877 |
| 62 | PTK2 | 0.86451572 |
| 63 | SIK3 | 0.85646620 |
| 64 | ZAK | 0.85441297 |
| 65 | PLK3 | 0.83361798 |
| 66 | ZAP70 | 0.83132124 |
| 67 | LRRK2 | 0.80284447 |
| 68 | PIM1 | 0.79689103 |
| 69 | IRAK3 | 0.78569362 |
| 70 | PRKCI | 0.78297159 |
| 71 | MAP3K12 | 0.76967022 |
| 72 | CHEK1 | 0.76511460 |
| 73 | ICK | 0.76187833 |
| 74 | CDK8 | 0.75555222 |
| 75 | ABL2 | 0.72431805 |
| 76 | MTOR | 0.71779026 |
| 77 | PDK3 | 0.71036787 |
| 78 | PDK4 | 0.71036787 |
| 79 | ALK | 0.70919804 |
| 80 | AKT3 | 0.70916767 |
| 81 | MAP2K2 | 0.70416340 |
| 82 | PASK | 0.70289450 |
| 83 | ARAF | 0.68343970 |
| 84 | STK4 | 0.66942778 |
| 85 | IRAK2 | 0.66347435 |
| 86 | DAPK3 | 0.63050118 |
| 87 | TLK1 | 0.60387421 |
| 88 | BLK | 0.60252171 |
| 89 | CDK2 | 0.59057302 |
| 90 | MET | 0.58926118 |
| 91 | FLT3 | 0.58659443 |
| 92 | MAP3K1 | 0.57528361 |
| 93 | MOS | 0.56429201 |
| 94 | BMX | 0.55944244 |
| 95 | MUSK | 0.55768687 |
| 96 | TTN | 0.55417089 |
| 97 | ILK | 0.54493368 |
| 98 | CSNK2A1 | 0.51981942 |
| 99 | NME1 | 0.51767457 |
| 100 | CSNK2A2 | 0.51354334 |
| 101 | MAP3K5 | 0.50212866 |
| 102 | AKT2 | 0.49614555 |
| 103 | RIPK1 | 0.49587529 |
| 104 | LIMK1 | 0.49148236 |
| 105 | PINK1 | 0.48896299 |
| 106 | PRKD3 | 0.48693176 |
| 107 | MAPK11 | 0.47082686 |
| 108 | PTK6 | 0.47059210 |
| 109 | IRAK4 | 0.46287036 |
| 110 | GRK6 | 0.44809783 |
| 111 | CDK9 | 0.44286364 |
| 112 | CAMK2G | 0.44059857 |
| 113 | STK3 | 0.42728421 |
| 114 | TGFBR1 | 0.41882527 |
| 115 | FGFR4 | 0.41543423 |
| 116 | CDK6 | 0.39397477 |
| 117 | MAPKAPK2 | 0.39074656 |
| 118 | DYRK2 | 0.38705307 |
| 119 | VRK1 | 0.38501605 |
| 120 | ATM | 0.38429152 |
| 121 | PRKG2 | 0.37443511 |
| 122 | EPHB1 | 0.36456476 |
| 123 | CDK11A | 0.36355939 |
| 124 | TYK2 | 0.36180414 |
| 125 | PDGFRA | 0.35886073 |
| 126 | CLK1 | 0.35724104 |
| 127 | CDK14 | 0.34203174 |
| 128 | PDPK1 | 0.33682280 |
| 129 | ERBB4 | 0.33401564 |
| 130 | TBK1 | 0.33165458 |
| 131 | CDK15 | 0.32576885 |
| 132 | RPS6KA1 | 0.32452838 |
| 133 | CSNK1G3 | 0.32362614 |
| 134 | PDK2 | 0.30622165 |
| 135 | CDK1 | 0.29400729 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 3.83696775 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.46633286 |
| 3 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.22323488 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 3.00641018 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.68903570 |
| 6 | RNA transport_Homo sapiens_hsa03013 | 2.68501308 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.48872781 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.44085706 |
| 9 | Ribosome_Homo sapiens_hsa03010 | 2.37190527 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.34064012 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.20486211 |
| 12 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.17237982 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 2.08123131 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.07826217 |
| 15 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.01591245 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.97433248 |
| 17 | Cell cycle_Homo sapiens_hsa04110 | 1.85973633 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.84222389 |
| 19 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.84197787 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.78696612 |
| 21 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.76944137 |
| 22 | Sulfur relay system_Homo sapiens_hsa04122 | 1.76731638 |
| 23 | Homologous recombination_Homo sapiens_hsa03440 | 1.75010057 |
| 24 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.71684884 |
| 25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64718928 |
| 26 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.59613439 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58365226 |
| 28 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.51285676 |
| 29 | Carbon metabolism_Homo sapiens_hsa01200 | 1.47664406 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.45534839 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44103640 |
| 32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.37339870 |
| 33 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.33973628 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33937032 |
| 35 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33530860 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.31203085 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27207084 |
| 38 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.26609450 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.23317693 |
| 40 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.21173664 |
| 41 | Lysosome_Homo sapiens_hsa04142 | 1.16938513 |
| 42 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.04716958 |
| 43 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.02020227 |
| 44 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01527025 |
| 45 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00788961 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 0.99691260 |
| 47 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.99512402 |
| 48 | RNA degradation_Homo sapiens_hsa03018 | 0.99370693 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97043972 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 0.96752201 |
| 51 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.95937357 |
| 52 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.95753709 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.94010409 |
| 54 | Galactose metabolism_Homo sapiens_hsa00052 | 0.93298358 |
| 55 | Prion diseases_Homo sapiens_hsa05020 | 0.93145300 |
| 56 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91345290 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.86755309 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.85420706 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.84641983 |
| 60 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83646285 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81904329 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.78872334 |
| 63 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.78295905 |
| 64 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75527402 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.74869103 |
| 66 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74476970 |
| 67 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72867216 |
| 68 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.71538204 |
| 69 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70798260 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69589557 |
| 71 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.69156302 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.69061094 |
| 73 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.68755230 |
| 74 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.66099622 |
| 75 | Legionellosis_Homo sapiens_hsa05134 | 0.65659532 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.63480310 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57008569 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.56794158 |
| 79 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.56556368 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55670281 |
| 81 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.55456883 |
| 82 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.55448643 |
| 83 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.55265885 |
| 84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.50179751 |
| 85 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49381800 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49116301 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.48884974 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.47242048 |
| 89 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46540939 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45596100 |
| 91 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.45303223 |
| 92 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45298166 |
| 93 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44311037 |
| 94 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.44203475 |
| 95 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43145751 |
| 96 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43020866 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.41870551 |
| 98 | Apoptosis_Homo sapiens_hsa04210 | 0.41856960 |
| 99 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41651940 |
| 100 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41596586 |
| 101 | Hepatitis B_Homo sapiens_hsa05161 | 0.41430131 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.41024062 |
| 103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.40728434 |
| 104 | Bladder cancer_Homo sapiens_hsa05219 | 0.40017273 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39959555 |
| 106 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39833312 |
| 107 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.39744318 |
| 108 | Hepatitis C_Homo sapiens_hsa05160 | 0.39207536 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.38752595 |
| 110 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.37578324 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.37577122 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34901751 |
| 113 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.33112363 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.31779577 |
| 115 | Shigellosis_Homo sapiens_hsa05131 | 0.30683724 |
| 116 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.30648121 |
| 117 | Huntingtons disease_Homo sapiens_hsa05016 | 0.30082859 |
| 118 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.29653224 |
| 119 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29300331 |
| 120 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.28883843 |
| 121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.28695895 |
| 122 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28304083 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.28069922 |
| 124 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.26294875 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.26256512 |
| 126 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.26063696 |
| 127 | Influenza A_Homo sapiens_hsa05164 | 0.25601910 |
| 128 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.25425699 |
| 129 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.25379453 |
| 130 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.24940854 |
| 131 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.20636628 |
| 132 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.20274714 |
| 133 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.19517957 |
| 134 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.17691787 |
| 135 | Retinol metabolism_Homo sapiens_hsa00830 | 0.16548736 |
| 136 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.16402039 |

